NeuShen Therapeutics Closes Pre-A Financing with ~$20M
/PRNewswire/ -- NeuShen Therapeutics, Inc., a biotechnology company focusing on developing innovative treatments for central nervous system (CNS) disorders...
Source: prnewswire.com
Binhui Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Binhui Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Binhui Biotech Today - Breaking & Trending Today
BridGene Biosciences Announces $38.5 Million Series B Financing to Further Develop Its Next Generation Chemoproteomics Platform and First-in-Class Oncology Drugs
/PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company leveraging a proprietary chemoproteomic platform to discover and develop small-molecule...
Source: prnewswire.com
Chinese biotech firm Binhui secures $93m Series C led by Temasek's Vertex Ventures, others
Chinese biotech firm Binhui secures $93m Series C led by Temasek’s Vertex Ventures, others Photo: Pixabay February 10, 2021 Gene-focused biotechnology player Wuhan Binhui Biotech on Wednesday announced the completion of a 600 million yuan ($93 million) Series C round funding jointly led by healthcare-focussed Share Capital, Temasek’s Vertex Ventures China, Qianhai FOF, and CICC Capital’s sub-fund. Returning investor Beijing Lapam Capital Management re-upped in the latest round, Binhui Biotech said in a WeChat post. Lapam had partnered Fortune Capital to seed 26.5 million yuan ($4 millio...
Source: dealstreetasia.com